Chronische Pankreatitis: Update Diagnostik und Therapie

Zusammenfassung

Hintergrund Die chronische Pankreatitis (CP) ist eine häufige Ursache für stationäre Einweisungen in die Gastroenterologie und ist mit einer reduzierten Lebensqualität und Lebenserwartung assoziiert. Die Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS) hat in der aktuellen S3-Leitlinie „Pankreatitis“ die neuesten Erkenntnisse von Epidemiologie, Diagnostik und Behandlung der akuten und chronischen Pankreatitis zusammengefasst. Hier werden praxisrelevante Aspekte für die chronische Pankreatitis zusammengefasst.

Ergebnisse Die häufigste Ursache der CP ist der chronische Alkoholabusus. Weitere Ursachen sind die hereditäre Pankreatitis, die Autoimmunpankreatitis, ein Hyperparathyreoidismus und idiopathische Formen der CP. Neben der klassischen hereditären Pankreatitis (PRSS1-Mutation), sind in den letzten Jahren eine Vielzahl an Genen identifiziert worden, die mit einem erhöhten Risiko für die Entwicklung einer idiopathischen CP assoziiert sind. In der konservativen Therapie der CP steht die Behandlung der exokrinen und endokrinen Insuffizienz sowie die Prävention und Behandlung von Sekundärkomplikationen (z.B. Osteoporose, Vitaminmangel, Mangelernährung) im Vordergrund. Lokale Komplikationen (Gallengangsstenose, Duodenalstenose, Pseudozysten und chronische Schmerzen) sollten in Pankreaszentren im interdisziplinären Konsens zwischen Viszeralchirurgie, Radiologie und der interventionellen Endoskopie abgestimmt werden. Während die Drainage von Pseudozysten die Domäne der Endoskopie ist, zeigen neueste Daten, dass die chirurgische Therapie von opiatabhängigen Schmerzen bei Patienten mit einem erweiterten Pankreasgang der Endoskopie überlegen ist.

Schlussfolgerung Die CP weist eine erhöhte Morbidität und Mortalität auf und führt häufig zu stationären Krankenhauseinweisungen. Das klinische Management dieser Patienten verlangt ein hohes Maß an Interdisziplinarität, um für jeden Patienten abhängig von den Komorbiditäten und dem Erkrankungsstadium ein individualisiertes Vorsorge- und Therapiekonzept zu entwerfen.

Abstract

Introduction Chronic pancreatitis (CP) is a frequent cause for hospitalization and is associated with impaired quality of life and reduced overall survival. The German Society for Gastroenterology (DGVS) has recently completed the S3-Guideline “Pancreatitis” that summarizes key findings on epidemiology, diagnostic and therapeutic concepts for acute and chronic pancreatitis. Here, we recapitulate the most relevant findings for clinicians regarding CP.

Results The most common cause of CP is chronic alcohol abuse, other causes are hereditary pancreatitis, autoimmune pancreatitis, hyperparathyroidism and idiopathic forms. Apart from the classical hereditary pancreatitis (PRSS1 mutation), a number of genetic associations have been discovered over the last years that are associated with an increased risk to develop idiopathic CP. The conservative management of CP is focused on the appropriate management of exocrine and endocrine insufficiency, and the prevention and treatment of secondary complications such as osteoporosis, vitamin deficiencies and malnutrition. Local complications (bile duct stenosis, duodenal stenosis, pseudocysts and chronic pain) should be managed in multidisciplinary teams in specialized pancreas centres with expert surgeons, radiologists and gastroenterologists. Infected or symptomatic pseudocysts should be primarily addressed by endoscopic drainage. In contrast, patients with chronic pain, dilated pancreas duct and opioid use should be considered for early surgical intervention.

Conclusion Chronic pancreatitis is associated with increased morbidity and mortality and often leads to hospital admissions. The clinical management of complex patients with local complications requires an interdisciplinary approach to tailor available therapeutic modalities depending on the stage of the disease and pre-existing comorbidities.

Schlüsselwörter

Chronische Pankreatitis - chronische Schmerzen - S3 Leitlinie - exokrine Insuffizienz - Gallengangsstenose - Pseudozyste

Keywords

chronic pancreatitis - chronic pain - S3 guideline - exocrine insufficiency - biliary stenosis - pseudocyst

Publikationsverlauf

Eingereicht: 26. Juli 2021

Angenommen nach Revision: 26. September 2021

Artikel online veröffentlicht:
19. November 2021

• Literatur

• 1 Beyer G, Hoffmeister A, Michl P. et al. S3-Leitlinie – Pankreatitis Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS); 2021 in press.
• 2 Lowenfels AB, Maisonneuve P, Cavallini G. et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol 1994; 89: 1467-1471 (PMID: 8079921)
• 3 Seicean A, Tantău M, Grigorescu M. et al. Mortality risk factors in chronic pancreatitis. J Gastrointestin Liver Dis 2006; 15: 21-26 (PMID: 16680228)
• 4 McWilliams RR, Maisonneuve P, Bamlet WR. et al. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas 2016; 45: 311-316 DOI: 10.1097/MPA.0000000000000392. (PMID: 26646264)
• 5 Mayerle J, Sendler M, Hegyi E. et al. Genetics, Cell Biology, and Pathophysiology of Pancreatitis. Gastroenterology 2019; 156: 1951-1968.e1 DOI: 10.1053/j.gastro.2018.11.081. (PMID: 30660731)
• 6 Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 2019; 16: 175-184 DOI: 10.1038/s41575-018-0087-5. (PMID: 30482911)
• 7 Völzke H, Lüdemann J, Mayerle J. et al. Prevalence and determinants of increased serum lipase levels in a general population. Pancreas 2008; 37: 411-417 DOI: 10.1097/MPA.0b013e31817f527d. (PMID: 18953254)
• 8 Durbec JP, Sarles H. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion 1978; 18: 337-350 DOI: 10.1159/000198221. (PMID: 750261)
• 9 Lin Y, Tamakoshi A, Hayakawa T. et al. Associations of alcohol drinking and nutrient intake with chronic pancreatitis: findings from a case-control study in Japan. Am J Gastroenterol 2001; 96: 2622-2627 DOI: 10.1111/j.1572-0241.2001.04121.x. (PMID: 11569685)
• 10 Kume K, Masamune A, Ariga H. et al. Alcohol Consumption and the Risk for Developing Pancreatitis: A Case-Control Study in Japan. Pancreas 2015; 44: 53-58 DOI: 10.1097/MPA.0000000000000256. (PMID: 25386904)
• 11 Beyer G, Habtezion A, Werner J. et al. Chronic pancreatitis. The Lancet 2020; 396: 499-512 DOI: 10.1016/S0140-6736(20)31318-0. (PMID: 32798493)
• 12 Sato T, Saito Y, Noto N. et al. Clinicopathological studies on the relationship between cholelithiasis and chronic pancreatitis. Tohoku J Exp Med 1974; 113: 97-111 DOI: 10.1620/tjem.113.97. (PMID: 4612874)
• 13 Misra SP, Dwivedi M. Do gallstones cause chronic pancreatitis?. Int J Pancreatol 1991; 10: 97-102 DOI: 10.1007/BF02924257. (PMID: 1757735)
• 14 Yan M-X, Li Y-Q. Gall stones and chronic pancreatitis: the black box in between. Postgrad Med J 2006; 82: 254-258 DOI: 10.1136/pgmj.2005.037192. (PMID: 16597812)
• 15 Bertin C, Pelletier A-L, Vullierme MP. et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012; 107: 311-317 DOI: 10.1038/ajg.2011.424.
• 16 Schneider A, Michaely H, Weiss C. et al. Prevalence and Incidence of Autoimmune Pancreatitis in the Population Living in the Southwest of Germany. Digestion 2017; 96: 187-198 DOI: 10.1159/000479316. (PMID: 28957814)
• 17 Maire F, Le Baleur Y, Rebours V. et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011; 106: 151-156 DOI: 10.1038/ajg.2010.314. (PMID: 20736934)
• 18 Hart PA, Kamisawa T, Brugge WR. et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62: 1771-1776 DOI: 10.1136/gutjnl-2012-303617. (PMID: 23232048)
• 19 Shimosegawa T, Chari ST, Frulloni L. et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-358 DOI: 10.1097/MPA.0b013e3182142fd2. (PMID: 21412117)
• 20 Wallace ZS, Naden RP, Chari S. et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol 2020; 72: 7-19 DOI: 10.1002/art.41120. (PMID: 31793250)
• 21 Whitcomb DC, Gorry MC, Preston RA. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145 DOI: 10.1038/ng1096-141. (PMID: 8841182)
• 22 Rosendahl J, Landt O, Bernadova J. et al. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated?. Gut 2013; 62: 582-592 DOI: 10.1136/gutjnl-2011-300645. (PMID: 22427236)
• 23 Rosendahl J, Kirsten H, Hegyi E. et al. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. Gut 2018; 67: 1855-1863 DOI: 10.1136/gutjnl-2017-314454. (PMID: 28754779)
• 24 Whitcomb DC, LaRusch J, Krasinskas AM. et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012; 44: 1349-1354 DOI: 10.1038/ng.2466. (PMID: 23143602)
• 25 Ammann RW, Muench R, Otto R. et al. Evolution and regression of pancreatic calcification in chronic pancreatitis. Gastroenterology 1988; 95: 1018-1028 DOI: 10.1016/0016-5085(88)90178-3. (PMID: 3410215)
• 26 Wang LW, Li ZS, de Li S. et al. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas 2009; 38: 248-254 DOI: 10.1097/MPA.0b013e31818f6ac1. (PMID: 19034057)
• 27 Mullady DK, Yadav D, Amann ST. et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut 2011; 60: 77-84 DOI: 10.1136/gut.2010.213835. (PMID: 21148579)
• 28 Dimcevski G, Sami SAK, Funch-Jensen P. et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 2007; 132: 1546-1556 DOI: 10.1053/j.gastro.2007.01.037. (PMID: 17408654)
• 29 DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-815 DOI: 10.1056/NEJM197304192881603. (PMID: 4693931)
• 30 Fitzsimmons D, Kahl S, Butturini G. et al. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 2005; 100: 918-926 DOI: 10.1111/j.1572-0241.2005.40859.x. (PMID: 15784041)
• 31 Chowdhury R, Bhutani MS, Mishra G. et al. Comparative analysis of direct pancreatic function testing versus morphological assessment by endoscopic ultrasonography for the evaluation of chronic unexplained abdominal pain of presumed pancreatic origin. Pancreas 2005; 31: 63-68 DOI: 10.1097/01.mpa.0000164451.69265.80. (PMID: 15968249)
• 32 Yasokawa K, Ito K, Kanki A. et al. Evaluation of pancreatic exocrine insufficiency by cine-dynamic MRCP using spatially selective inversion-recovery (IR) pulse: Correlation with severity of chronic pancreatitis based on morphological changes of pancreatic duct. Magn Reson Imaging 2018; 48: 70-73 DOI: 10.1016/j.mri.2017.12.007. (PMID: 29217490)
• 33 Lankisch PG, Schmidt I, König H. et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42: 551-554 DOI: 10.1136/gut.42.4.551.
• 34 Keller J, Layer P, Brückel S. et al. 13C-mixed triglyceride breath test for evaluation of pancreatic exocrine function in diabetes mellitus. Pancreas 2014; 43: 842-848 DOI: 10.1097/MPA.0000000000000121. (PMID: 24763073)
• 35 Hoffmeister A, Mayerle J, Beglinger C. et al. S3-Leitlinie Chronische Pankreatitis: Definition, Ätiologie, Diagnostik, konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2012; 50: 1176-1224 DOI: 10.1055/s-0032-1325479.
• 36 Beyer G, Mahajan UM, Budde C. et al. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology 2017; 153: 1544-1554.e2 DOI: 10.1053/j.gastro.2017.08.073. (PMID: 28918191)
• 37 Olesen SS, Bouwense SAW, Wilder-Smith OHG. et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 2011; 141: 536-543 DOI: 10.1053/j.gastro.2011.04.003.
• 38 Gurusamy KS, Lusuku C, Davidson BR. Pregabalin for decreasing pancreatic pain in chronic pancreatitis. Cochrane Database Syst Rev 2016; 2: CD011522 DOI: 10.1002/14651858.CD011522.pub2. (PMID: 26836292)
• 39 Malfertheiner P, Mayer D, Büchler M. et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995; 36: 450-454 DOI: 10.1136/gut.36.3.450. (PMID: 7698708)
• 40 Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M. et al. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000 DOI: 10.1111/j.1365-2036.2005.02390.x. (PMID: 15813835)
• 41 El Kurdi B, Babar S, El Iskandarani M. et al. Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression. Clin Transl Gastroenterol 2019; 10: e00072 DOI: 10.14309/ctg.0000000000000072. (PMID: 31517648)
• 42 Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M. et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 484-488 DOI: 10.1016/j.cgh.2007.01.004. (PMID: 17445754)
• 43 Weiss FU, Budde C, Lerch MM. Specificity of a Polyclonal Fecal Elastase ELISA for CELA3. PLoS ONE 2016; 11: e0159363 DOI: 10.1371/journal.pone.0159363. (PMID: 27459204)
• 44 O'Keefe SJ, Cariem AK, Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol 2001; 32: 319-323 DOI: 10.1097/00004836-200104000-00008. (PMID: 11276275)
• 45 Singh S, Midha S, Singh N. et al. Dietary counseling versus dietary supplements for malnutrition in chronic pancreatitis: a randomized controlled trial. Clin Gastroenterol Hepatol 2008; 6: 353-359 DOI: 10.1016/j.cgh.2007.12.040. (PMID: 18328440)
• 46 Cahen DL, Gouma DJ, Laramée P. et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 2011; 141: 1690-1695 DOI: 10.1053/j.gastro.2011.07.049. (PMID: 21843494)
• 47 Lakhtakia S, Reddy N, Dolak W. et al. Long-term outcomes after temporary placement of a self-expanding fully covered metal stent for benign biliary strictures secondary to chronic pancreatitis. Gastrointest Endosc 2020; 91: 361-369.e3 DOI: 10.1016/j.gie.2019.08.037. (PMID: 31494135)
• 48 Issa Y, Kempeneers MA, Bruno MJ. et al. Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial. JAMA 2020; 323: 237-247 DOI: 10.1001/jama.2019.20967. (PMID: 31961419)
• 49 Abdallah AA, Krige JEJ, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford) 2007; 9: 421-428 DOI: 10.1080/13651820701774883. (PMID: 18345288)
• 50 Kahl S, Zimmermann S, Genz I. et al. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol 2003; 98: 2448-2453 DOI: 10.1111/j.1572-0241.2003.08667.x. (PMID: 14638347)
• 51 Lankisch PG, Weber-Dany B, Maisonneuve P. et al. Pancreatic pseudocysts: prognostic factors for their development and their spontaneous resolution in the setting of acute pancreatitis. Pancreatology 2012; 12: 85-90 DOI: 10.1016/j.pan.2012.02.007. (PMID: 22487516)
• 52 Bradley EL, Clements JL, Gonzalez AC. The natural history of pancreatic pseudocysts: A unified concept of management. The American Journal of Surgery 1979; 137: 135-141 DOI: 10.1016/0002-9610(79)90024-2. (PMID: 758840)
• 53 Kamal A, Singh VK, Akshintala VS. et al. CT and MRI assessment of symptomatic organized pancreatic fluid collections and pancreatic duct disruption: an interreader variability study using the revised Atlanta classification 2012. Abdom Imaging 2015; 40: 1608-1616 DOI: 10.1007/s00261-014-0303-x. (PMID: 25425489)
• 54 Cahen D, Rauws E, Fockens P. et al. Endoscopic drainage of pancreatic pseudocysts: long-term outcome and procedural factors associated with safe and successful treatment. Endoscopy 2005; 37: 977-983 DOI: 10.1055/s-2005-870336. (PMID: 16189770)
• 55 Zeissig S, Sulk S, Brueckner S. et al. Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections. Gut 2019; 68: 945-946 DOI: 10.1136/gutjnl-2018-316581. (PMID: 29678933)
• 56 Lyu Y, Li T, Wang B. et al. Comparison Between Lumen-Apposing Metal Stents and Plastic Stents in Endoscopic Ultrasound-Guided Drainage of Pancreatic Fluid Collection: A Meta-analysis and Systematic Review. Pancreas 2021; 50: 571-578 DOI: 10.1097/MPA.0000000000001798. (PMID: 33939671)